Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Danae M, Hamouda"'
Autor:
Alexander J. Didier, Anthony Nigro, Zaid Noori, Mohamed A. Omballi, Scott M. Pappada, Danae M. Hamouda
Publikováno v:
Frontiers in Artificial Intelligence, Vol 7 (2024)
IntroductionMachine learning (ML) techniques have gained increasing attention in the field of healthcare, including predicting outcomes in patients with lung cancer. ML has the potential to enhance prognostication in lung cancer patients and improve
Externí odkaz:
https://doaj.org/article/0c8270d3c0d2490fb8a018320d2515a3
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100188- (2022)
Background: The epidermal growth factor receptor (EGFR) gene harbors a variety of pathogenic variants in non-small cell lung cancer (NSCLC) with several mutations within exons 18–21 serving as common targets for tyrosine kinase inhibitor (TKI) ther
Externí odkaz:
https://doaj.org/article/2fd5633b57dc4bf0aba9a7f70878b264
Autor:
Justin Fortune Creeden, Nisha S. Nanavaty, Katelyn R. Einloth, Cassidy E. Gillman, Laura Stanbery, Danae M. Hamouda, Lance Dworkin, John Nemunaitis
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Homologous recombination and DNA repair are important for genome maintenance. Genetic variations in essential homologous recombination genes, including BRCA1 and BRCA2 results in homologous recombination deficiency (HRD) and can be a target
Externí odkaz:
https://doaj.org/article/6bf59a6f145d4a74b3e551503e742c00
Autor:
Daniel J. Craig, Morgan M. Bailey, Olivia B. Noe, Kada K. Williams, Laura Stanbery, Danae M. Hamouda, John J. Nemunaitis
Publikováno v:
Cancer Treatment and Research Communications, Vol 30, Iss , Pp 100507- (2022)
Tumor mutation burden (TMB) is often used as a biomarker for immunogenicity and prerequisite for immune checkpoint inhibitor (ICI) therapy. However, it is becoming increasingly evident that not all tumors with high TMB respond to ICIs as expected. It
Externí odkaz:
https://doaj.org/article/3b5f3462cb7f4ad3a40068c1b4ba12ef
Publikováno v:
Cancer Management and Research. 14:729-738
First-line therapy for treatment of advanced urothelial carcinoma includes combination platinum-based chemotherapies, though resistance and long-term toxicity concerns to these regimens cause limitations in progression-free survival and overall survi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fb36b638916222aa3aa9ad02cc5afe1
https://doi.org/10.2147/cmar.s227323
https://doi.org/10.2147/cmar.s227323
Publikováno v:
Blood. 140:8046-8047
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2567f7549485751352620704d4c21163
https://doi.org/10.1182/blood-2022-169477
https://doi.org/10.1182/blood-2022-169477
Autor:
Caleb, Spencer, Ziad, Abuhelwa, Azizullah, Beran, Anas, Alsughayer, Taha, Sheikh, Drew, Oostra, Ragheb, Assaly, Danae M, Hamouda
Publikováno v:
American Journal of Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0bf279ae5d8d62c21f37f332c456e9b
https://doi.org/10.1097/mjt.0000000000001522
https://doi.org/10.1097/mjt.0000000000001522
Autor:
Ziad Abuhelwa, Azizullah Beran, Navkirat Kahlon, Wasef Sayeh, Waleed Khokher, Ragheb Assaly, Danae M. Hamouda
Publikováno v:
American journal of therapeutics.
e19084 Background: Midostaurin, an oral multikinase inhibitor including inhibition of KIT D816V, is approved for the treatment of advanced systemic mastocytosis (SM). Few studies have investigated the use of midostaurin in patients with advanced SM,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968423eba27ced55b171f5cb88293a2f
https://pubmed.ncbi.nlm.nih.gov/35446286
https://pubmed.ncbi.nlm.nih.gov/35446286
Autor:
Alexander Didier, Lauren Fang, Jennifer Stiene, Shabab Ud Din, Caleb Spencer, Danae M. Hamouda
Publikováno v:
Journal of Clinical Oncology. 41:756-756
756 Background: The incidence of pancreatic cancer among young adults has sharply risen over the past decade. Young adults often utilize online educational media, such as YouTube videos, for information about their disease. These may be subject to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f8b2c5c08484bfb27c11ad998caa755
https://doi.org/10.1200/jco.2023.41.4_suppl.756
https://doi.org/10.1200/jco.2023.41.4_suppl.756
Autor:
Navkirat, Kahlon, Sishir, Doddi, Rame, Yousif, Sana, Najib, Taha, Sheikh, Ziad, Abuhelwa, Cameron, Burmeister, Danae M, Hamouda
Publikováno v:
JAMA Network Open. 5:e2245269
ImportanceMelanoma accounts for most of the deaths due to skin cancer. In the past decade, effective US Food and Drug Administration (FDA)–approved therapies for melanoma have emerged.ObjectiveTo review changes in the long-term melanoma mortality r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::915368ec1c7181072da4d2f6a444a037
https://doi.org/10.1001/jamanetworkopen.2022.45269
https://doi.org/10.1001/jamanetworkopen.2022.45269